IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
-0.49%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$312M
AUM Growth
+$312M
(+3,153%)
Cap. Flow
+$279M
Cap. Flow
% of AUM
89.54%
Top 10 Holdings %
Top 10 Hldgs %
48.33%
Holding
84
New
6
Increased
59
Reduced
1
Closed
18
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$26.7M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$21.2M |
| 3 |
Incyte
INCY
|
$18M |
| 4 |
Alkermes
ALKS
|
$13.2M |
| 5 |
Gilead Sciences
GILD
|
$12.3M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$1.94M |
| 2 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$121K |
| 3 |
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
|
$107K |
| 4 |
Amicus Therapeutics
FOLD
|
$94.6K |
| 5 |
Immunovant
IMVT
|
$60K |
Sector Composition
| 1 | Healthcare | 99.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
PTC Therapeutics
PTCT
$4.41B
| $1.06M | 0.34% |
21,000
+20,158
| +2,394% | +$1.01M |
|
52
Rocket Pharmaceuticals
RCKT
$358M
| $1.01M | 0.32% |
63,000
+62,132
| +7,158% | +$991K |
|
53
Xenon Pharmaceuticals
XENE
$2.99B
| $918K | 0.29% |
25,500
+24,726
| +3,195% | +$890K |
|
54
Insmed
INSM
$30.3B
| $864K | 0.28% |
40,100
+39,309
| +4,970% | +$847K |
|
55
Arvinas
ARVN
$580M
| $756K | 0.24% |
+17,000
| New | +$756K |
|
56
BioCryst Pharmaceuticals
BCRX
$1.74B
| $718K | 0.23% |
57,000
+56,398
| +9,368% | +$710K |
|
57
Axsome Therapeutics
AXSM
$6.09B
| $625K | 0.2% |
14,000
+13,465
| +2,517% | +$601K |
|
58
Ironwood Pharmaceuticals
IRWD
$201M
| $621K | 0.2% |
60,000
+59,308
| +8,571% | +$614K |
|
59
HUTCHMED
HCM
$2.62B
| $602K | 0.19% |
68,000
+67,141
| +7,816% | +$594K |
|
60
Allogene Therapeutics
ALLO
$249M
| $539K | 0.17% |
50,000
+49,430
| +8,672% | +$533K |
|
61
Iovance Biotherapeutics
IOVA
$800M
| $536K | 0.17% |
56,000
+52,989
| +1,760% | +$507K |
|
62
Relmada Therapeutics
RLMD
$48.8M
| $370K | 0.12% |
10,000
+9,810
| +5,163% | +$363K |
|
63
Madrigal Pharmaceuticals
MDGL
$9.7B
| $348K | 0.11% |
5,350
+4,967
| +1,297% | +$323K |
|
|
ALBO
64
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $312K | 0.1% |
+16,093
| New | +$312K |
|
65
Mirum Pharmaceuticals
MIRM
$3.75B
| $193K | 0.06% |
+9,219
| New | +$193K |
|
|
CCXI
66
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – |
-3,000
| Closed | -$121K |
|
|
ICPT
67
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-441
| Closed | -$32K |
|
|
KRTX
68
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-1,567
| Closed | -$12.4K |
|
|
GMDA
69
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| – | – |
-187
| Closed | -$107K |
|
|
TSVT
70
DELISTED
2seventy bio
TSVT
| – | – |
-48
| Closed | -$3.67K |
|
|
SWTX
71
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-401
| Closed | -$16.3K |
|
72
Protagonist Therapeutics
PTGX
$3.62B
| – | – |
-128
| Closed | -$16.2K |
|
73
Prothena Corp
PRTA
$452M
| – | – |
-407
| Closed | -$15K |
|
74
Ionis Pharmaceuticals
IONS
$9.64B
| – | – |
-1,703
| Closed | -$46.1K |
|
|
75
Immunovant
IMVT
$2.91B
| – | – |
-233
| Closed | -$60K |
|